Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial.

Saved in:
Bibliographic Details
Title: Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial.
Authors: Rieser NM; Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich and University of Zurich, Lenggstrasse 31, Zurich 8032, Switzerland., Bitar R; Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich and University of Zurich, Lenggstrasse 31, Zurich 8032, Switzerland., Halm S; Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich and University of Zurich, Lenggstrasse 31, Zurich 8032, Switzerland., Rossgoderer C; Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich and University of Zurich, Lenggstrasse 31, Zurich 8032, Switzerland., Gubser LP; Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich and University of Zurich, Lenggstrasse 31, Zurich 8032, Switzerland., Thévenaz M; Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich and University of Zurich, Lenggstrasse 31, Zurich 8032, Switzerland., Kreis Y; Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich and University of Zurich, Lenggstrasse 31, Zurich 8032, Switzerland., von Rotz R; Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich and University of Zurich, Lenggstrasse 31, Zurich 8032, Switzerland., Nordt C; Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich and University of Zurich, Lenggstrasse 31, Zurich 8032, Switzerland., Visentini M; Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich and University of Zurich, Lenggstrasse 31, Zurich 8032, Switzerland., Moujaes F; Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich and University of Zurich, Lenggstrasse 31, Zurich 8032, Switzerland., Engeli EJE; Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich and University of Zurich, Lenggstrasse 31, Zurich 8032, Switzerland., Ort A; Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich and University of Zurich, Lenggstrasse 31, Zurich 8032, Switzerland., Seifritz E; Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich and University of Zurich, Lenggstrasse 31, Zurich 8032, Switzerland., Vollenweider FX; Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich and University of Zurich, Lenggstrasse 31, Zurich 8032, Switzerland., Herdener M; Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich and University of Zurich, Lenggstrasse 31, Zurich 8032, Switzerland., Preller KH; Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich and University of Zurich, Lenggstrasse 31, Zurich 8032, Switzerland.
Source: EClinicalMedicine [EClinicalMedicine] 2025 Mar 14; Vol. 82, pp. 103149. Date of Electronic Publication: 2025 Mar 14 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2589-5370
DOI:10.1016/j.eclinm.2025.103149